Cargando…
From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
BACKGROUND: Following the recognition that morbidity and mortality due to malaria had dramatically increased in the last three decades, in 2002 the government of Zambia reviewed its efforts to prevent and treat malaria. Convincing evidence of the failing efficacy of chloroquine resulted in the initi...
Autores principales: | Sipilanyambe, Naawa, Simon, Jonathon L, Chanda, Pascalina, Olumese, Peter, Snow, Robert W, Hamer, Davidson H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248595/ https://www.ncbi.nlm.nih.gov/pubmed/18230140 http://dx.doi.org/10.1186/1475-2875-7-25 |
Ejemplares similares
-
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane(®)) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2006) -
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
por: Zurovac, Dejan, et al.
Publicado: (2007) -
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia
por: Barnes, Karen I, et al.
Publicado: (2009) -
Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia
por: Hamainza, Busiku, et al.
Publicado: (2014)